Stock Events

Stock Events

SK Biopharmaceuticals. (326030.KQ) Q2 2025 Earnings

9MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

85

829

1,573

2,318

Details

Expected EPS

252

Actual EPS

236

Surprise EPS

-16

Surprise Percent

+6.46%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 236 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.